Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 8/20 | 0.58 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.58 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.53 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | GBA1 | P04062 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15137456 | 1.00 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8MAPK1 | |
| SCHEMBL8429329 | 1.00 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8MAPK1 | |
| SCHEMBL1668605 | 1.00 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8MAPK1 | |
| SCHEMBL9232535 | 1.00 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8MAPK1 | |
| SCHEMBL1666797 | 1.00 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8MAPK1 | |
| SCHEMBL1666654 | 1.00 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8MAPK1 | |
| SCHEMBL5577129 | 1.00 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8MAPK1 | |
| SCHEMBL3171119 | 1.00 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8MAPK1 | |
| SCHEMBL9235193 | 1.00 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8MAPK1 | |
| SCHEMBL11359586 | 1.00 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4621407-A1 | METHOD FOR PREPARING PEPTIDE-CONTAINING SAMPLE | Kazusa DNA Research Institute (JP) | 2025-09-24 | — | — | EP | disclosed |
| US-20250195409-A1 | METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES | Ananda Scientific, Inc. (US) | 2025-06-19 | — | — | US | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-10703870-B2 | Composition for optical film, and optical film comprising same | LG CHEM, LTD. (KR) | 2020-07-07 | — | — | US | disclosed |
| US-10386674-B2 | Light-emitting film | LG CHEM, LTD. (KR) | 2019-08-20 | — | — | US | disclosed |
| US-10359175-B2 | Light-emitting film | LG CHEM, LTD. (KR) | 2019-07-23 | — | — | US | disclosed |
| US-20180113361-A1 | LIGHT-EMITTING FILM | LG CHEM, LTD. (KR) | 2018-04-26 | — | — | US | disclosed |
| US-20180051144-A1 | COMPOSITION FOR OPTICAL FILM, AND OPTICAL FILM COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-02-22 | — | — | US | disclosed |
| US-20170191638-A1 | LIGHT-EMITTING FILM | LG CHEM, LTD. (KR) | 2017-07-06 | — | — | US | disclosed |
| WO-2016144133-A1 | COMPOSITION FOR OPTICAL FILM, AND OPTICAL FILM COMPRISING SAME | 주식회사 엘지화학 | 2016-09-15 | — | — | WO | disclosed |
| WO-2016024828-A1 | LIGHT-EMITTING FILM | 주식회사 엘지화학 | 2016-02-18 | — | — | WO | disclosed |
| US-20110124586-A1 | EXTERNAL PREPARATION FOR SKIN, AND WRINKLE-REPAIRING AGENT | KAO CORPORATION (JP) | 2011-05-26 | — | — | US | disclosed |
| US-20090240044-A1 | PROCESS FOR THE REDUCTION OF ENDOTOXINS IN A PLASMID PREPARATION USING A CARBOHYDRATE NON-IONIC DETERGENT WITH SILICA CHROMATOGRAPHY | SIGMA-ALDRICH COMPANY (US) | 2009-09-24 | — | — | US | disclosed |
| US-7531308-B2 | Process for the reduction of endotoxins in a plasmid preparation using a carbohydrate non-ionic detergent with silica chromatography | SIGMA-ALDRICH CO. (US) | 2009-05-12 | — | — | US | disclosed |
| US-20050245733-A1 | Process for the reduction of endotoxins in a plasmid preparation using a carbohydrate non-ionic detergent with silica chromatography | SIGMA-ALDRICH CO. | 2005-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090240044-A1 | PROCESS FOR THE REDUCTION OF ENDOTOXINS IN A PLASMID PREPARATION USING A CARBOHYDRATE NON-IONIC DETERGENT WITH SILICA CHROMATOGRAPHY | SI, DDOST, LITAF | LGALS3 73/4885LGALS1 40/4885LGALS9 138/4885 |
| US-20250195409-A1 | METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES | CNR2, CNR1, FAAH | LGALS3 2882/4885LGALS1 3139/4885LGALS9 3312/4885 |
| US-20050245733-A1 | Process for the reduction of endotoxins in a plasmid preparation using a carbohydrate non-ionic detergent with silica chromatography | SI, DDOST, LITAF | LGALS3 73/4885LGALS1 40/4885LGALS9 138/4885 |
| US-20110124586-A1 | EXTERNAL PREPARATION FOR SKIN, AND WRINKLE-REPAIRING AGENT | GLA, LGALS1, UGGT1 | LGALS3 80/4885LGALS1 2/4885LGALS9 71/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.